174 related articles for article (PubMed ID: 11525306)
21. Molecular biology of gastric cancer.
Cervantes A; Rodríguez Braun E; Pérez Fidalgo A; Chirivella González I
Clin Transl Oncol; 2007 Apr; 9(4):208-15. PubMed ID: 17462972
[TBL] [Abstract][Full Text] [Related]
22. Significance of aquaporins' expression in the prognosis of gastric cancer.
Thapa S; Chetry M; Huang K; Peng Y; Wang J; Wang J; Zhou Y; Shen Y; Xue Y; Ji K
Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29678898
[TBL] [Abstract][Full Text] [Related]
23. Cadherin-catenin adhesion system and mucin expression: a comparison between young and older patients with gastric carcinoma.
Silva EM; Begnami MD; Fregnani JH; Pelosof AG; Zitron C; Montagnini AL; Soares FA
Gastric Cancer; 2008; 11(3):149-59. PubMed ID: 18825309
[TBL] [Abstract][Full Text] [Related]
24. Emerging new prognostic markers of gastric tumors besides PTK7.
Kapoor S
J Surg Oncol; 2013 Mar; 107(4):450. PubMed ID: 22767429
[No Abstract] [Full Text] [Related]
25. [New molecular prognostic markers in gastric carcinoma].
Yoshida K; Yasui W; Yokozaki H; Nishimoto N; Kagawa Y; Toge T; Tahara E; Yoshida T; Terada M
Gan To Kagaku Ryoho; 1998 Nov; 25(13):2021-7. PubMed ID: 9838902
[TBL] [Abstract][Full Text] [Related]
26. Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1.
van der Post RS; Vogelaar IP; Manders P; van der Kolk LE; Cats A; van Hest LP; Sijmons R; Aalfs CM; Ausems MG; Gómez García EB; Wagner A; Hes FJ; Arts N; Mensenkamp AR; van Krieken JH; Hoogerbrugge N; Ligtenberg MJ
Gastroenterology; 2015 Oct; 149(4):897-906.e19. PubMed ID: 26072394
[TBL] [Abstract][Full Text] [Related]
27. Personalized medicine in gastric cancer: Where are we and where are we going?
Jácome AA; Coutinho AK; Lima EM; Andrade AC; Dos Santos JS
World J Gastroenterol; 2016 Jan; 22(3):1160-71. PubMed ID: 26811654
[TBL] [Abstract][Full Text] [Related]
28. [Molecular biology and immunohistochemical studies of Her2/neu oncogene in stomach cancer].
Jähne J; Urmacher C; Albino A; Meyer HJ; Pichlmayr R
Chirurg; 1994 Apr; 65(4):307-11. PubMed ID: 7912666
[TBL] [Abstract][Full Text] [Related]
29. Molecular biology of gastric cancer.
El-Rifai W; Powell SM
Semin Radiat Oncol; 2002 Apr; 12(2):128-40. PubMed ID: 11979414
[TBL] [Abstract][Full Text] [Related]
30. New concepts of molecular biology on gastric carcinogenesis.
Kountouras J; Zavos C; Chatzopoulos D
Hepatogastroenterology; 2005; 52(64):1305-12. PubMed ID: 16001683
[TBL] [Abstract][Full Text] [Related]
31. Molecular biology of pancreatic cancer; oncogenes, tumour suppressor genes, growth factors, and their receptors from a clinical perspective.
Sakorafas GH; Tsiotou AG; Tsiotos GG
Cancer Treat Rev; 2000 Feb; 26(1):29-52. PubMed ID: 10660490
[TBL] [Abstract][Full Text] [Related]
32. Gene amplification of CCNE1, CCND1, and CDK6 in gastric cancers detected by multiplex ligation-dependent probe amplification and fluorescence in situ hybridization.
Ooi A; Oyama T; Nakamura R; Tajiri R; Ikeda H; Fushida S; Dobashi Y
Hum Pathol; 2017 Mar; 61():58-67. PubMed ID: 27864121
[TBL] [Abstract][Full Text] [Related]
33. NDRG4 in gastric cancer determines tumor cell proliferation and clinical outcome.
Zhang Z; She J; Yang J; Bu X; Ji G; Zhu S; He S; Chu D
Mol Carcinog; 2018 Jun; 57(6):762-771. PubMed ID: 29500881
[TBL] [Abstract][Full Text] [Related]
34. Forkhead Box F2 Suppresses Gastric Cancer through a Novel FOXF2-IRF2BPL-β-Catenin Signaling Axis.
Higashimori A; Dong Y; Zhang Y; Kang W; Nakatsu G; Ng SSM; Arakawa T; Sung JJY; Chan FKL; Yu J
Cancer Res; 2018 Apr; 78(7):1643-1656. PubMed ID: 29374064
[TBL] [Abstract][Full Text] [Related]
35. Molecular biology of colorectal cancer.
Gryfe R; Swallow C; Bapat B; Redston M; Gallinger S; Couture J
Curr Probl Cancer; 1997; 21(5):233-300. PubMed ID: 9438104
[TBL] [Abstract][Full Text] [Related]
36. Knockdown of CEACAM19 suppresses human gastric cancer through inhibition of PI3K/Akt and NF-κB.
Zhao H; Xu J; Wang Y; Jiang R; Li X; Zhang L; Che Y
Surg Oncol; 2018 Sep; 27(3):495-502. PubMed ID: 30217308
[TBL] [Abstract][Full Text] [Related]
37. Fibroblast growth factor receptor 2 expression, but not its genetic amplification, is associated with tumor growth and worse survival in esophagogastric junction adenocarcinoma.
Tokunaga R; Imamura Y; Nakamura K; Ishimoto T; Nakagawa S; Miyake K; Nakaji Y; Tsuda Y; Iwatsuki M; Baba Y; Sakamoto Y; Miyamoto Y; Saeki H; Yoshida N; Oki E; Watanabe M; Oda Y; Bass AJ; Maehara Y; Baba H
Oncotarget; 2016 Apr; 7(15):19748-61. PubMed ID: 26933914
[TBL] [Abstract][Full Text] [Related]
38. [Somatic genetics of breast cancer].
Bièche I; Lidereau R
Bull Cancer; 1997 Jan; 84(1):83-96. PubMed ID: 9180865
[TBL] [Abstract][Full Text] [Related]
39. The clinical significance of platelet-derived growth factors (PDGFs) and their receptors (PDGFRs) in gastric cancer: A systematic review and meta-analysis.
Qian H; Appiah-Kubi K; Wang Y; Wu M; Tao Y; Wu Y; Chen Y
Crit Rev Oncol Hematol; 2018 Jul; 127():15-28. PubMed ID: 29891108
[TBL] [Abstract][Full Text] [Related]
40. Down-regulated expression of OPCML predicts an unfavorable prognosis and promotes disease progression in human gastric cancer.
Xing X; Cai W; Ma S; Wang Y; Shi H; Li M; Jiao J; Yang Y; Liu L; Zhang X; Chen M
BMC Cancer; 2017 Apr; 17(1):268. PubMed ID: 28407749
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
